1. Home
  2. CMPX vs AVD Comparison

CMPX vs AVD Comparison

Compare CMPX & AVD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CMPX
  • AVD
  • Stock Information
  • Founded
  • CMPX 2014
  • AVD 1969
  • Country
  • CMPX United States
  • AVD United States
  • Employees
  • CMPX N/A
  • AVD N/A
  • Industry
  • CMPX Biotechnology: Pharmaceutical Preparations
  • AVD Agricultural Chemicals
  • Sector
  • CMPX Health Care
  • AVD Industrials
  • Exchange
  • CMPX Nasdaq
  • AVD Nasdaq
  • Market Cap
  • CMPX 217.4M
  • AVD 171.3M
  • IPO Year
  • CMPX N/A
  • AVD N/A
  • Fundamental
  • Price
  • CMPX $1.43
  • AVD $6.26
  • Analyst Decision
  • CMPX Strong Buy
  • AVD Strong Buy
  • Analyst Count
  • CMPX 2
  • AVD 3
  • Target Price
  • CMPX $9.00
  • AVD $16.67
  • AVG Volume (30 Days)
  • CMPX 429.9K
  • AVD 451.4K
  • Earning Date
  • CMPX 08-12-2024
  • AVD 08-08-2024
  • Dividend Yield
  • CMPX N/A
  • AVD 1.92%
  • EPS Growth
  • CMPX N/A
  • AVD N/A
  • EPS
  • CMPX N/A
  • AVD N/A
  • Revenue
  • CMPX $850,000.00
  • AVD $585,049,000.00
  • Revenue This Year
  • CMPX N/A
  • AVD N/A
  • Revenue Next Year
  • CMPX $950.68
  • AVD $4.69
  • P/E Ratio
  • CMPX N/A
  • AVD N/A
  • Revenue Growth
  • CMPX N/A
  • AVD 2.73
  • 52 Week Low
  • CMPX $0.77
  • AVD $4.95
  • 52 Week High
  • CMPX $2.34
  • AVD $14.28
  • Technical
  • Relative Strength Index (RSI)
  • CMPX 60.03
  • AVD 45.76
  • Support Level
  • CMPX $1.19
  • AVD $5.61
  • Resistance Level
  • CMPX $1.61
  • AVD $5.87
  • Average True Range (ATR)
  • CMPX 0.10
  • AVD 0.25
  • MACD
  • CMPX 0.02
  • AVD 0.17
  • Stochastic Oscillator
  • CMPX 43.34
  • AVD 85.98

About CMPX Compass Therapeutics Inc.

Compass Therapeutics Inc is a clinical-stage biopharmaceutical company that develops proprietary antibody therapeutics intended to engage the immune system to treat both solid tumors and hematological malignancies. It is engaged in drug discovery by leveraging its proprietary antibody discovery engine to broadly drug the immune system and identify optimal combinations empirically. Through StitchMabs and common light chain platforms, these combinatorial insights can be rapidly translated into tailored bispecifics with monoclonal-like manufacturability. Its pipeline is comprised of three product candidates, CTX-009, CTX-471, and CTX-8371.

About AVD American Vanguard Corporation ($0.10 Par Value)

American Vanguard Corp is a United States-based diversified specialty and agricultural products company. It manufactures and formulates chemicals for crops, turf and ornamental plants, and human and animal health protection. These chemicals include insecticides, fungicides, herbicides, molluscicides, growth regulators, and soil fumigants, which are marketed in liquid, powder, and granular forms.

Share on Social Networks: